Cargando…
CD93 overexpresses in liver hepatocellular carcinoma and represents a potential immunotherapy target
BACKGROUND: Liver hepatocellular carcinoma (LIHC) is one of the malignant tumors with high incidence as well as high death, which is ranked as the sixth most common tumor and the third highest mortality worldwide. CD93, a transmembrane protein, has been widely reported to play an important role in d...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359974/ https://www.ncbi.nlm.nih.gov/pubmed/37483608 http://dx.doi.org/10.3389/fimmu.2023.1158360 |